Vitamin D Supplementation Guidelines for Pre‑conception Fertility

Target Serum 25‑Hydroxyvitamin D Level

• Aim for a serum 25(OH)D concentration of ≥30 ng/mL (≥75 nmol/L), with an optimal range of 30–50 ng/mL (75–125 nmol/L) for reproductive‑age individuals attempting conception. 1

Recommended Daily Supplementation (Baseline‑Uncertain or Low Status)

• Initiate 2,000–4,000 IU (50–100 µg) of vitamin D₃ (cholecalciferol) daily at least 2–3 months before planned conception. This dose is endorsed as safe and effective for achieving sufficiency. 1

Dosing Algorithm According to Baseline 25(OH)D

Loading and maintenance recommendations are based on expert consensus. 3 [1 for maintenance]

Monitoring Protocol

• Baseline measurement of serum 25(OH)D should be obtained before starting supplementation or within the first month.
• Re‑check after 3 months to evaluate response and adjust dosing.
• Continue monitoring every 3–6 months throughout the pre‑conception period (supported by obesity‑focused research). 4

Essential Co‑interventions

• Ensure daily calcium intake of 1,000–1,500 mg from diet and supplements to enable vitamin D activity. 1
• Take vitamin D₃ with the largest meal containing fat to maximize absorption. 1
• Maintain folic acid 400 µg daily; for individuals with BMI > 30 kg/m², increase to 4–5 mg daily. (Higher dose recommendation supported by obesity literature). 4

High‑Risk Populations Requiring Higher Baseline Doses

• Dark‑skinned individuals, those with limited sun exposure, obesity, or vegetarian diets should start with 2,000–4,000 IU daily because standard 600–800 IU is insufficient for these groups. 1

Post‑Bariatric Surgery Considerations

• Minimum 1,000–2,000 IU daily with trimester‑interval monitoring is advised.
• Target serum 25(OH)D ≥20 ng/mL (≥50 nmol/L) with normal parathyroid hormone levels.
• If oral therapy fails, intramuscular vitamin D₃ may be considered. 5 [4 for target level] [3 for IM option]

Safety Profile

• Daily doses up to 4,000 IU are fully safe for adults; serum 25(OH)D should not exceed 100 ng/mL.
• Toxicity is rare, occurring only with prolonged intake >10,000 IU daily.
• No cases of hypercalcemia or hypercalciuria have been reported with doses ≤4,000 IU during pregnancy. 2

Critical Pitfalls to Avoid

• Do not rely on the general population recommendation of 600 IU daily for women trying to conceive. 1
• Do not postpone baseline vitamin D testing; early assessment is essential for timely repletion. 1
• Do not assume efficacy without a 3‑month follow‑up test, given wide inter‑individual variability. 3
• Do not use vitamin D₂ (ergocalciferol) when vitamin D₃ is available, as D₃ is more effective at raising and maintaining serum levels. 3

Expected Reproductive Outcomes

• Achieving vitamin D sufficiency (≥30 ng/mL) before conception is associated with a ≈70 % increase in clinical pregnancy rates and a ≈7 % improvement in cumulative live‑birth rates for women undergoing fertility treatment.
• Optimal outcomes are most evident when target levels are reached by the first trimester. 2